Chlordiazepoxide Hydrochloride And Clidinium Bromide Capsule
Product Images NDC 75826-134

Product Visual Gallery

This gallery contains 3 technical images submitted to the FDA as part of the official labeling for Chlordiazepoxide Hydrochloride And Clidinium Bromide (NDC 75826-134). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Winder Laboratories Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Chemical Structure (Chlordiazepoxide 01)

Chemical structure of Chlordiazepoxide Hydrochloride showing its molecular framework including a chlorinated aromatic ring, diazepine ring, and hydrochloride group.*

FDA Label Image

Chemical Structure (Chlordiazepoxide 02)

Chemical structure diagram of the active ingredient shown in the product image, depicting the molecular arrangement including benzene rings and bromine atom as part of the compound's chemical formula.*

FDA Label Image

Principal Display Panel (100 Capsule Bottle)

Label for Chlordiazepoxide Hydrochloride and Clidinium Bromide Capsules, USP, 5 mg/2.5 mg strength. The label indicates a package of 100 capsules with prescription-only status. It includes storage instructions, dosage information, and manufacturer details: Winder Laboratories LLC, Winder, Georgia. The label features a barcode and an unvarnished area.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.